Dahlen D D, Lin N L, Liu Y C, Broudy V C
Department of Medicine, Division of Hematology, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104-2499, USA.
Leuk Res. 2001 May;25(5):413-21. doi: 10.1016/s0145-2126(00)00122-3.
Stem cell factor (SCF) is a growth factor that promotes the survival, proliferation, and differentiation of hematopoietic cells. SCF and its receptor, Kit, are normally present in both cell surface and soluble forms. Both forms of Kit can bind SCF. However, the function of soluble Kit is unknown. In order to determine if soluble Kit can modulate SCF activity, we produced a fusion protein, Kit-Fc, comprised of the extracellular domain of murine Kit and the Fc portion of human IgG(1) and investigated its ability to bind 125I-SCF and to inhibit SCF-stimulated hematopoietic colony growth in vitro. Stable cell lines expressing Kit-Fc were generated and Kit-Fc was purified to greater than 95% purity. Scatchard analysis demonstrated that Kit-Fc binds iodinated SCF with high affinity (Kd 570 pM). Kit-Fc also bound to transmembrane SCF displayed on the surface of fibroblasts. The murine mast cell line IC2 was engineered to express murine Kit on the cell surface and was demonstrated to proliferate in the presence of SCF. Kit-Fc completely blocked SCF-stimulated proliferation of IC2-Kit cells, but not IL-3-stimulated growth of IC2-Kit cells, demonstrating the specificity of Kit-Fc. We investigated the ability of Kit-Fc to block SCF-stimulated murine hematopoietic colony growth. Kit-Fc blocked SCF-stimulated erythroid colony growth as effectively as a neutralizing anti-Kit monoclonal antibody, ACK2, but did not block erythropoietin-stimulated erythroid colony growth. Likewise, Kit-Fc blocked SCF-stimulated myeloid colony growth as effectively as ACK2 antibody, but did not block IL-3- or GM-CSF-stimulated myeloid colony growth. These results indicate that a form of soluble Kit binds SCF with high affinity, and can specifically block the ability of SCF to stimulate hematopoietic colony growth, suggesting that one function of soluble Kit may be to modulate SCF bioactivity.
干细胞因子(SCF)是一种促进造血细胞存活、增殖和分化的生长因子。SCF及其受体Kit通常以细胞表面形式和可溶性形式存在。两种形式的Kit都能结合SCF。然而,可溶性Kit的功能尚不清楚。为了确定可溶性Kit是否能调节SCF活性,我们制备了一种融合蛋白Kit-Fc,它由小鼠Kit的胞外结构域和人IgG(1)的Fc部分组成,并研究了其结合125I-SCF的能力以及在体外抑制SCF刺激的造血集落生长的能力。生成了表达Kit-Fc的稳定细胞系,并将Kit-Fc纯化至纯度大于95%。Scatchard分析表明,Kit-Fc以高亲和力(Kd 570 pM)结合碘化SCF。Kit-Fc也与成纤维细胞表面展示的跨膜SCF结合。对小鼠肥大细胞系IC2进行基因工程改造,使其在细胞表面表达小鼠Kit,并证明其在SCF存在下能增殖。Kit-Fc完全阻断了SCF刺激的IC2-Kit细胞增殖,但不阻断IL-3刺激的IC2-Kit细胞生长,证明了Kit-Fc的特异性。我们研究了Kit-Fc阻断SCF刺激的小鼠造血集落生长的能力。Kit-Fc阻断SCF刺激的红系集落生长的效果与中和抗Kit单克隆抗体ACK2一样有效,但不阻断促红细胞生成素刺激的红系集落生长。同样,Kit-Fc阻断SCF刺激的髓系集落生长的效果与ACK2抗体一样有效,但不阻断IL-3或GM-CSF刺激的髓系集落生长。这些结果表明,一种可溶性Kit形式以高亲和力结合SCF,并能特异性阻断SCF刺激造血集落生长的能力,提示可溶性Kit的一个功能可能是调节SCF的生物活性。